CD38 and neoplasm: have also revealed that when cocultured with MM cells, isatuximab induces NK‐lymphocyte activation beyond tumor‐NK cell cross talk, through increased expression of CD69 and CD137 after Fc binding and CD38 transmembrane signaling.82